Regenesome Inc., based in Tokyo, Japan, has unveiled its latest product, the SAISEI Regenesome Supplement, set to hit the market in August 2025. This functional food is the result of Regenesome’s extensive analysis of Japanese health data in partnership with Japan System Techniques Co., Ltd., as well as collaborations with fermentation technology and longevity science startups under the “Fermentation and Longevity Fund” program by Space Seed Holdings.
With a primary focus on Agingcare, Regenesome is dedicated to creating products that promote health and beauty, ultimately contributing to societal well-being. The SAISEI Regenesome Supplement, formulated in conjunction with Euglena Co., Ltd., merges advanced biotechnology with traditional wellness principles from Okinawa’s renowned “Blue Zone,” incorporating a blend of scientifically proven health ingredients.
The key components of the SAISEI Regenesome Supplement include Euglena gracilis, known for its abundance of essential nutrients, sake lees powder rich in koji mold and yeast-derived nutrients, Kalahari watermelon extract studied for its potential circulatory and hydrating benefits, and ergothioneine recognized for its antioxidant properties. This combination of ingredients underscores Regenesome’s commitment to delivering a product that aligns with both scientific research and holistic wellness philosophies.
The SAISEI brand essence revolves around three core values: Regeneration, emphasizing revitalization of life energy; Prime, enabling peak performance; and Uniqueness, offering products of distinct value. By encapsulating these values, Regenesome aims to provide consumers with a unique and enriching experience through its products.
Looking ahead, Regenesome plans to manufacture the SAISEI Regenesome Supplement in collaboration with Okinawa Ukondo Co., Ltd., while receiving promotional support from the Butterfly Pea Research Institute. The company envisions a future where it continues to develop scientifically validated food and supplement products, forging partnerships with research institutions and businesses both domestically and internationally to pioneer innovative solutions for healthy aging.
The Fermentation and Longevity Fund, managed by Space Seed Holdings, plays a pivotal role in supporting early-stage projects in fermentation technology, anti-aging, and longevity science. By targeting proof-of-concept studies and fostering collaboration among academia, industry, and startups, this program accelerates the translation of research into practical applications.
Regenesome’s core mission revolves around developing novel solutions in aging control and regenerative medicine using nanoparticles like exosomes. With the establishment of the Takanawa Longevity Lab at LiSH in Tokyo, the company aims to expedite its business and research endeavors. Regenesome’s ultimate goal is to pioneer groundbreaking healthcare technologies for Earth and space, extending healthy lifespans and supporting humanity’s future beyond our planet.
Key Takeaways:
– The SAISEI Regenesome Supplement blends advanced biotechnology with traditional wellness principles to offer functional food focused on anti-aging and wellness.
– Regenesome’s collaboration with Okinawa Ukondo Co., Ltd., and the Butterfly Pea Research Institute underscores its commitment to developing innovative products for healthy aging.
– The company’s involvement in the Fermentation and Longevity Fund highlights its dedication to supporting early-stage projects in fermentation technology, anti-aging, and longevity science.
– Regenesome’s long-term vision includes creating breakthrough healthcare technologies for Earth and space, aiming to extend healthy lifespans and facilitate humanity’s expansion beyond our planet.
Tags: regenerative medicine
Read more on japantimes.co.jp